With the analysis among 128 patents, we discovered top 36 key players by total patent application. Thrombolytic Science International LLC, Vascular Laboratories, Inc., Shanghai Tasly Pharmaceutical Co. Ltd. are dominant in this area. They take 31.25% of the total patent filing.
Massachusetts, United States
Patent: 15
Shanghai Shi, China
Patent: 12
Gyeonggi-do, South Korea
Patent: 5
California, United States
Patent: 5
With the analysis among 5 patents, we discovered top 1 start-ups by total patent application.
With the analysis among related 21 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing Shanghai Tasly Pharmaceutical Co. Ltd., National Cancer Center Korea, Rin Institute, Inc. take 80.95% of patent filing during this period.
Shanghai Shi, China
Patent: 7
Gyeonggi-do, South Korea
Patent: 5
Jiangsu Sheng, China
Patent: 3
Massachusetts, United States
Patent: 1
Hebei Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Tianjin Shi, China
Patent: 1
With the analysis among related 21 patents in last 5 years, we discover 7 new entrants. National Cancer Center Korea, Rin Institute, Inc., GemPharmatech Co., Ltd. are the most active new entrants in this area.
Gyeonggi-do, South Korea
Patent: 5
Jiangsu Sheng, China
Patent: 3
Hebei Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Tianjin Shi, China
Patent: 1
With the analysis among 14 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Beijing Shi, China
Patent: 1
Beijing Shi, China
Patent: 1